Neonatal Diabetes

2

Review clinical trials related to Neonatal Diabetes. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

China Monogenic Diabetes Registry

This observational study aims to establish a digital registry, screening platform for patients with monogenic diabetes using internet-based and mobile application technologies. The primary objectives are to: Characterize the genetic landscape of monogenic diabetes in the Chinese population, including pathogenic variants and their distribution Participants will: * Enroll in the monogenic diabetes registry via mobile application or web-based platform * Undergo molecular genetic testing to establish a definitive diagnosis

Participants needed: 5,000
Trial details
Biological sex: AllType: ObservationalSponsor: Tianjin Medical University General HospitalUpdated: Mar 25, 2026Locations: 1Duration: 5 Years
Eligibility criteria

Diabetes diagnosed before 25 years of age; OR diabetes diagnosed before 35 years... [+2]

Secondary diabetes [+1]

Status: Recruiting

Monogenic Diabetes Misdiagnosed as Type 1

The study has two aims: 1. To (1a) determine the frequency of monogenic diabetes misdiagnosed as type 1 diabetes (T1D) and (2) to define an algorithm for case selection. 2. To discover novel genes whose mutations cause monogenic diabetes misdiagnosed as T1D.

Participants needed: 5,000
Trial details
Age: 1-25Biological sex: AllType: ObservationalSponsor: McGill University Health Centre/Research Institute of the McGill University Health CentreUpdated: Dec 10, 2024Locations: 1
Eligibility criteria

Diagnosis of diabetes under the age of 25 as either type 1 or undetermined type.

Existing T1D autoantibody testing with a positive result